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Intra-vascular access is an unavoidable tool in sophisticated modern medical practice,
and catheter-related infection remains a leading cause of nosocomial infections, parti-
cularly in intensive care units where it is associated with significant patient morbidity,
mortality, and additional hospital costs. The incidence of catheter-related bloodstream
infection ranges from 2 to 14 episodes per 1000 catheter-days. On average, microbiolo-
gically documented, device-related bloodstream infections complicate the use of a central
venous line in three to five per 100 cases. But this represents only the visible part of the
iceberg and most episodes of clinical sepsis are nowadays considered to be catheter-
related. We briefly review the pathophysiology of these infections, highlighting the
importance of the skin insertion site and the intravenous line hub as principal sources of
colonization and infection. Principles of therapy are briefly addressed. A large proportion
of these infections are preventable and this has been the objective of creating precise
guidelines. It was recently suggested that the situation may evolve with the introduction
of antibiotic/antiseptic-coated devices, whose impact on the epidemiology of antibiotic
resistance remains to be determined. Recently, educational programs and/or a global
preventive strategy based on the strict application of specific preventive measures and
careful control of all factors associated with infection proved to be even more effective
than coated devices in reducing rates of infection. Practical aspects regarding educational
approaches will help clinicians to adapt and incorporate educational programs into
clinical practice.
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I N T R O D U C T I O N
The Institute of Medicine in Washington recently
estimated that preventable adverse events in the
United States, including nosocomial infections,
were responsible for 44 000–98 000 deaths annually
and represent a cost of $17 to $29 billion [1]. Mostly
based on extrapolation from two studies only, this
report has generated considerable debate in the
medical literature [2–9]. Nosocomial infections
(NI) now concern 5–15% of hospitalized patients
and can lead to complications in 25–50% of those
admitted to intensive care units (ICUs) [10]. Pneu-
monia related to mechanical ventilation, intra-
abdominal infections following trauma or surgery,
and bacteremias or sepsis related to intravascular
devices account for more than 80% of these types
of infections [11,12]. Accordingly, their prevention
should become a priority target of health-care
systems.
Definitions
Catheter-related infections (CRIs) include coloni-
zation of the device, skin exit-site infection
and device-related bloodstream infection [13–19]
(Table 1).
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Microbiological criteria are a matter of debate
for experts and in the absence of a standard refer-
ence technique a choice has to be made between
sensitivity and specificity according to scientific
considerations and technical or economic
restraints. According to the data regularly
reported by the National Nosocomial Infection
Surveillance (NNIS) system more than 85% of pri-
mary bacteraemias are catheter-related [20–23].
The concept of bloodstream infection includes
Table 1 Definitions of catheter-related infections and diagnostic culturesa
Type of infection
Definitions with sensitivity and specificity of the type of culture performed for the diagnosis of
infection
Catheter colonization In the absence of any clinical signs of infection at the insertion site of the vascular access:
Type of microbiological
technique applied in
the laboratory
Cut-off valuesb Sensitivity Specificity
quantitative culture
(Brun–Buisson
technique) [14]:
100 CFUs 94% 92%
quantitative culture
(sonication, vortexing
technique) [16]:
1000 CFUs 94% 92%
semiquantitative culture
(roll-plate technique) [15]:
15 CFUs 85% 85%
Exit-site infection Microbiologically documented: a positive (semi)quantitative catheter culture in the presence
of clinical signs of infection (erythema, tenderness, induration
or purulence) at the insertion site of any vascular access
Clinically documented: a clinical infection (erythema, tenderness, induration
or purulence) at the insertion site
Bloodstream
infection
Primary bloodstream infection: bacteremia (or fungemia) without documented distal source
of infection. This includes those resulting from an intravenous
or arterial line infection.
Clinical sepsis: requires one of the following signs or symptoms with no other
recognized cause: (i) fever (>38 8C); (ii) hypotension (systolic
blood pressure 90 mmHg); (iii) oliguria (<20 mL/ h) and the
presence of all of the following conditions: (i) blood culture
not performed or no organism detected in blood, (ii) no
apparent infection at another site, (iii) clinical response to
empiric antimicrobial therapy after catheter removal and/or
change
Catheter-related
bloodstream
infection
Isolation of the same organism (i.e. identical species, antibiogram) from a quantitative culture of the
distal catheter segment and from the blood of a patient with clinical symptoms of sepsis and no
other apparent source of infection
Type of microbiological technique applied to
perform blood cultures
Sensitivity Specificity
Standard blood cultures (two sets with at least
one drawn percutaneously) [17]
91% 86%
Quantitative blood culture (differ-
ential quantitative cultures of two sets with
at least one drawn percu-
taneously) [18]
79% 94%
Differential time blood culture (differential time of
two sets of blood cultures drawn simultaneously,
percutaneously and from the suspected
vascular access) [19]
91% 94%
In the absence of catheter culture, defervescence after removal of an implicated
catheter from a patient with primary bloodstream infection is considered as indirect
evidence of catheter-related bloodstream infection
aAdapted from references [13,17].
bCFUs: colony-forming units.
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Table 2 Colonization and catheter-related bloodstream infection rates in selected ICU series with antiseptic/antibiotic
impregnated and nonimpregnated central venous lines
Author
Number in
study
Catheter
colonization
Catheter-related
bloodstream infections
Non-impregnated catheters
Bach [33]a 117 36 (30.8%) 3 (2.5%)
Hannan [35]b 177 71 (40.2%) 8 (4.7%)
Heard [31]c 157 82 (52.2%) 6 (3.8%)
Loo [34]d 81 25 (30.9%) 3 (3.9%)
Maki [25]e 195 47 (24.1%) 9 (4.6%)
Marik [36]f 39 11 (28.2%) 2 (5.1%)
Raad [26]g 136 32 (23.6%) 7 (5.0%)
Tennenberg [30]h 145 32 (22.4%) 9 (6.4%)
van Heerden [32]i 26 10 (38.5%) 0 –
Silver-sulphadiazine/chlorhexidine-impregnated catheters
Bach [33]a 116 21 (18.1%) 0 –
Hannan [35]b 174 47 (27.0%) 3 (1.7%)
Heard [31]c 151 60 (39.7%) 5 (3.3%)
Loo [34]d 77 12 (15.6%) 3 (3.3%)
Maki [25]e 208 28 (13.5%) 2 (1.0%)
Marik [36]f 36 7 (19.4%) 1 (2.8%)
Tennenberg [30]h 137 8 (5.8%) 5 (3.8%)
van Heerden [32]i 28 4 (14.3%) 0 –
Darouiche [27]j 382 87 (22.8%) 13 (3.4%)
Minocyclin/rifampin-impregnated catheters
Marik [36]f 38 4 (10.5%) 0 –
Raad [26]g 130 11 (8.0%) 0 –
Darouiche [27]j 356 28 (7.5%) 1 (0.3%)
aQuantitative level of bacterial colonization 52 17 vs. 256 86 CFUs for silver-sulphadiazine/chlorhexidine-impregnated
as compared to non-impregnated catheters, respectively, P< 0.05. No significant differences for catheter-related
bloodstream infections.
bSemiquantitative analysis of bacterial counts for colonization for silver-sulphadiazine/chlorhexidine-impregnated as
compared to non-impregnated catheters P< 0.01. No significant differences for catheter-related bloodstream infections.
cOdds ratio for colonization only: 0.59 [CI 0.34–0.97] for silver-sulphadiazine/chlorhexidine-impregnated as compared to
non-impregnated catheters, respectively, P¼ 0.04.
dCatheter-tip-positive cultures: for silver-sulphadiazine/chlorhexidine-impregnated as compared to non-impregnated
catheters P< 0.05. No significant differences for catheter-related bloodstream infections.
eOdds ratio for colonization: 0.56 [CI 0.36–0.89] for silver-sulphadiazine/chlorhexidine-impregnated as compared to non-
impregnated catheters, respectively, P< 0.005. Odds ratio for catheter-related bloodstream infection: 0.21 [CI 0.03–0.95] for
silver-sulphadiazine/chlorhexidine-impregnated catheter as compared to non-impregnated catheters, respectively,
P¼ 0.03.
fSemiquantitative cultures of distal segment: for minocyclin/rifampin-coated as compared to non-impregnated catheters
P¼ 0.5. No significant differences for catheter-related bloodstream infections.
gOdds ratio for colonization: 0.25 [CI 0.12–0.53] for minocyclin/rifampin-coated as compared to non-impregnated
catheters, respectively, P< 0.001. The rates of catheter-related bloodstream infection per 1000 catheter-days were 7.34 for
non-impregnated and 0 for impregnated catheters (P< 0.01, binomial exact test).
hRisk reduction for colonization only: 43% for silver-sulphadiazine/chlorhexidine-impregnated as compared to non-
impregnated catheters, respectively, P< 0.001.
iSemiquantitative cultures of distal segment: for silver-sulphadiazine/chlorhexidine-impregnated as compared to non-
impregnated catheters P< 0.05. No significant differences for catheter-related bloodstream infections.
jOdds ratio for colonization: 0.35 [CI 0.23–0.52] for minocyclin/rifampin-coated as compared to silver-sulphadiazine/
chlorhexidine-impregnated catheters, respectively, P< 0.001. Odds ratio for catheter-related bloodstream infection: 0.08 [CI
0.01–0.63] for micocyclin/rifampin-coated as compared to silver-sulphadiazine/chlorhexidine-impregnated catheters,
respectively, P< 0.0001.
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not only primary bacteremia, but also clinical
sepsis. Secondary bacteremia, included in some
reports, should not be considered as catheter-
related as it is related to another documented focus
of infection.
Epidemiology and impact
Bloodstream infections represented 12% of all NI
reported in 10 038 patients from 1417 ICUs in the
European Prevalence of Infection in Intensive Care
(EPIC) study [24]. As previously mentioned, the
NNIS system reported that most nosocomial
bloodstream infections are related to intravascular
access, with rates substantially higher among
patients with central venous catheters (CVCs) than
among those with peripheral lines [11,12]. More
than 50% of ICU patients are already equipped
with at least one central line and it is generally
reported that micro-organisms eventually colonize
20–30% of these. The prevalence of catheter-
related bloodstream infection (CR-BSI) in the
studies published in the 1990s ranged from 2.5%
to 6.5% [25–36] (Table 2). However, comparisons
between different types of ICUs are more accurate
when these infections are reported as incidence-
densities related to CVC, and they range between
2.3 and 16.8 episodes per 1000 catheter-days
[12,20–23,37–47] (Table 3).
Studies have determined the impact of CRI on
patient morbidity and hospital costs in ICUs.
Recent case–control studies reported no attributa-
ble mortality, but overmatching may have played
a role and resulted in a possible underestimation
[32,48–54] (Table 4).
Pathophysiology and risk factors
Four distinct pathways may be identified in the
infection process of CRIs (Figure 1). The two major
pathways are the external and internal bacterial
colonization of the catheter surface, both even-
tually leading to catheter-tip colonization, with
the potential for subsequent bacteraemia [11].
Table 3 Catheter-related nosocomial infections rates in selected ICUs
Author [ref]
Type of
ICU Period
Number
of units
Bloodstream infections
per 1000 CVC-days
NNISa [22] medical 1997–99 135 5.3 (3.6–7.1)b
NNISa [20] coronary 1997–99 112 4.0 (1.7–6.3)b
NNISa [12] surgical 1997–99 157 5.1 (2.6–7.0)b
NNISa [23] mixedc 1992–98 135 5.9 (4.0–7.8)b
NNISa [23] mixedd 1992–98 69 5.1 (2.6–7.0)b
NNISa [21] paediatric 1997–99 73 6.9 (4.1–9.3)b
Brasic [37] mixed 1990–97 1 11.3
Gastmeier [38] mixed 1994 89 4.9
Legras [39] mixed 1995 5 4.8
Sherertz [40] mixed 1997 6 3.3e
Sherertz [40] mixed 1997 6 2.4f
Finkelstein [41] mixed 1997–99 1 12.0
Eggimann [42] medical 1995–96 1 6.6g
Eggimann [42] medical 1997 1 2.3h
Wallace [43] surgical 1997–99 1 8.0
Wallace [43] trauma 1995–97 1 9.1
Weber [44] burn 1990–91 1 4.9
Sing-Naz [45] pediatric 1993 1 8.9
Sing-Naz [45] pediatric 1995 1 16.8
Gastmeier [46] pediatric 1994–95 73 12.5 (5.7–24.7)b
Simon [47] pediatric 1998 1 10.7
aNational Nosocomial Infection Surveillance (NNIS) system.
b50th percentile (25th to 75th).
cNon-major teaching hospitals.
dMajor teaching hospitals.
eBefore implementation of an educational programme targeted at the reduction of catheter-related infections.
fAfter implementation of an educational programme targeted at the reduction of catheter-related infections.
gBefore implementation of a global strategy targeted at the reduction of catheter-related infections.
hAfter implementation of a global strategy targeted at the reduction of catheter-related infections.
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The key factors for pathogenesis include bacter-
ial adherence and host defence mechanisms. Host
glycoproteins, such as fibrinogen, fibronectin, col-
lagen and laminin, adsorbed on the surface of
intravenous devices, form a layer that enhances
bacterial adherence to foreign material, in parti-
cular, Staphylococcus aureus and coagulase-nega-
tive staphylococci. In addition, some strains
produce a mucoid exopolymeric substance (slime),
conferring some protection against antimicrobial
agents and interfering with neutrophil function
[55].
Skin colonization is a strong predictor of CRIs,
and several studies have demonstrated a high
association between significant distal catheter-tip
colonization and CR-BSI [15,56]. Accordingly,
external surface pathway infection may start with
the colonization of the skin insertion site by micro-
organisms of the skin flora that may move by
capillary action through the transcutaneous part
of the dermal tunnel surrounding the catheter.
This phenomenon was already considered as the
major source of CRIs. Internal surface pathway
infection may occur by colonization of the hub and
intraluminal surface of the catheter [57]. The exact
role of the manipulations necessary for the repla-
cement of administration sets, infusion of fluids or
drugs, and hemodynamic monitoring or blood
sampling is not yet precisely established. How-
ever, frequent opening of the hub is now viewed as
a potential cause of CRIs [15,25,27,56,57], the inci-
dence of which increases in any case with the
duration of placement [58]. Additional risk factors,
such as the catheter material, its localization, or the
type of care, are currently viewed as specific tar-
gets for preventive measures and will be discussed
further.
Hematogenous seeding of the catheter during
bloodstream infection of any origin represents a
third pathway of CRIs [59].
Finally, contamination of the fluids or drugs
intravenously administered constitutes another
process responsible for CRIs, sometimes resulting
in outbreaks. Uncommon micro-organisms such as
Enterobacter spp., Serratia marcescens, Malasezia fur-
fur, or Candida parapsilosis are identified in some
circumstances [60].
Table 4 Impact of nosocomial bloodstream infection (BSI) in selected groups of patients in ICUs
Mortality Attributable
Author Type of BSI
Year
of publication
Study
period
Number
of cases Crude Attributable LOSa (days) Costs ($)
Smith [48] nosocomialb 1991 1986–89 34 82% 30%
Relo [49] nosocomialb 1994 1990–92 111 65% 35%d 8.0 40 000
Pittet [50] nosocomialb 1994 1988–90 86 50% 35% 6.5 29 000
Pittet [51] catheter-related 1994 1988–90 20 45% 25% 20.0
Wisplinghoff [32] nosocomiale 1998 1990–92 29 31% 16%
Soufir [52] catheter-related 1999 1990–95 38 50% 29% 10.0 35 000
DiGiovine [53] nosocomialf 1999 1994–96 68 35% 4%g 20.0 4000
Rello [54] catheter-related 2000 1992–99 49 22% 13%g
aLOS, Length of stay.
bIncludes both primary and secondary bloodstream infections.
cPrimary coagulase-negative staphylococci (CNS) bacteremia only.
dAttributable mortality was determined by simple comparison with the crude mortality of all patients who did not develop
a bloodstream infection.
eAcinetobacter baumannii nosocomial bloodstream infections only.
fIncludes primary bloodstream infections only.
gDifferences are non-significant.
Figure 1 Colonization pathways involved in intravenous
catheter-related infection. External and internal catheter
surface colonization pathways involve colonization of the
skin insertion site, and hub, respectively. Additional
pathways include microbial contamination of the infusate
(so-called ‘intrinsic contamination’), and hematogenous
seeding.
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Microbiology
Most of the micro-organisms implicated in CRIs
arise from the skin flora [11,15,27,30,31,61]
(Table 5). Gram-positive cocci are responsible for
at least two-thirds of the infections. Coagulase-
negative staphylococci (60% Staphylococcus epider-
midis) are the leading bacteria cultured from
catheters, but enterococci are not uncommon
[16,27,30,31]. The recent emergence of vancomy-
cin-resistant enterococci (VRE), accounting for
3.8% of bloodstream infections reported in NNIS
hospitals between 1989 and 1993, is particularly
alarming [62]. The importance of this pathogen in
terms of CRI remains to be studied [62]. Staphylo-
coccus aureus is responsible for 5–15% of the infec-
tions and is associated with a higher rate of
complications [61,63].
Gram-negative bacilli are responsible for a high-
er proportion of CRIs in ICU than in non-ICU
patients. They are due to colonization of invasive
monitoring pressure systems, complicated remote
infections, or a high degree of orotracheal coloni-
zation [56].
Candida spp. have emerged as important patho-
gens of CRIs and account for a high proportion of
the dramatic increase in the rate of candidemia
over the last decades [64]. They represented more
than 30% of pathogens reported from 1992 to 1998
in 204 mixed ICUs participating in the NNIS sys-
tem [23], confirming that intravascular devices
constitute the leading source of nosocomial candi-
demia.
Diagnosis
As local signs may be completely absent, clinical
diagnosis of CVC-related infections may be
difficult. In addition, thrombophlebitis may be
of non-infectious origin and may render eventual
clinical criteria neither sensitive nor specific.
Microbiological criteria are then essential to estab-
lish the presence of CRI. Various methods for
culturing the insertion site, the catheter, and the
blood have been described and a choice must be
made according to preferred sensitivity or speci-
ficity [13,17,19] (Table 1).
Culture of the skin insertion site appears to be
very sensitive in detecting colonization, but since
all colonized patients will not develop CRI, it may
not be systematically indicated in the absence of
local signs of thrombophlebitis. Nevertheless, the
absence of micro-organisms at the skin insertion
site might have a high negative predictive value
for the detection of CVC colonization and thus
permit the avoidance of unnecessary catheter
replacement [65,66].
Several methods are used to culture catheters.
The choice of the optimal segment to be cultured
is controversial. Cultures from proximal intr-
adermal portions are more predictive for coloniza-
tion, but positive distal cultures are more sensitive
and specific for CRIs. Quantitative cultures using
the flush, sonication, vortex and centrifugation
techniques allow the identification of micro-
organisms from both the internal and the external
surfaces of the catheters [16]. They are highly
sensitive in detecting CR-BSIs; but some are diffi-
cult to generalize in current routine practice [14].
Semiquantitative culture techniques have been
widely used since their introduction by Maki in
1977 [15]. A 2-inch (5-cm) distal portion of catheter
should be transmitted immediately to the labora-
tory in a dry sterile container. The catheter is rolled
four times over the surface of a sheep-blood agar
plate and the number of micro-organisms is deter-
mined after 48 h of incubation. The presence of
>15 colony-forming units (CFUs) of a single
organism per catheter is considered to indicate
infection rather than colonization [15]. The limita-
tions of the technique include that only micro-
organisms from the external surface of the catheter
are cultured and that the cut-off may underscore
CVC-related infections; internal lumen coloniza-
tion may predominate with increased catheteriza-
tion time. Rapid diagnosis of CRI might be
obtained by direct microscopic examination of
the catheter tip stained with Gram or acridine
orange techniques. In a cohort of 400 ICU patients,
Gowardman et al. recently reported that this
Table 5 Micro-organisms associated with catheter-related
bloodstream infection
Type of micro-organism Proportiona
Coagulase-negative staphylococci 60–70%
Staphylococcus aureus 5–15%
Candida spp. 5–10%
Enterobacteriacae 5–10%
Enterococci 2–4%
Methicillin-resistant Staphylococcus aureus <5%
Burkholderia spp.b <2%
Malassezia spp.b <2%
aLarge variations according to local epidemiology of
micro-organisms’ resistance to antimicrobials.
bOccasionally responsible for outbreaks.
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technique was negative in the 12 catheters subse-
quently shown to be responsible for a BSI [67].
Although useful, these methods are time-consum-
ing; they depend on the skill of the observer and
may not be routinely used [68].
Importantly, cut-off for the diagnosis of CRI
varies according to the technique used: in parti-
cular, quantitative culture techniques using soni-
cation (1000 CFUs) [16], vortex (100 CFUs) [14];
and roll-plate semiquantitative technique
(>15 CFUs) [15].
Quantitative blood culture technique, in which
there is a differential count of micro-organisms in
blood taken simultaneously from the catheter and
from a peripheral vein, has proven useful in pre-
dicting CRIs. A single bacterial count of
>100 CFUs/mL in the catheter blood specimen
can be suggestive of CR-BSI in the presence of a
positive peripheral blood culture. Not routinely
used in clinical practice, this complex technique
may also help facilitate monitoring the efficacy of
antibacterial treatment to be monitored if the
catheter is left in place [69]. The measurement of
the differential time to positivity between blood
drawn from the catheter port (hub-blood) and
peripheral blood cultures was recently suggested
as a potentially reliable tool for diagnosis of CR-
BSI [70]. In a group of 93 patients, in whom a CVC
was consecutively removed for suspicion of CRI
over a 14-month period, the same group included
a diagnosis of definite CR-BSI in 16 of 17 ICU
patients in whom a positive hub-blood culture
was detected at least 2 h earlier than peripheral
blood culture. A CRI was excluded in 10 of the 11
patients in whom the differential time to positivity
was lower than 2 h, conferring a 91% sensitivity
and 94% specificity to this cut-off [19]. If further
studies did confirm these data, this simple tech-
nique may be imposed in hospital clinical practice,
using automatic devices for detection of positive
blood cultures.
Treatment strategies
In general, removal of a catheter suspected to be
infected is strongly recommended. Catheter reten-
tion may result in a several-fold higher risk for
recurrence of BSI. Removal is mandatory in severe
or complicated infections such as shock, persistent
fever, or bacteremia, or with certain micro-organ-
isms (S. aureus, Gram-negative bacilli, Candida
spp.) [11,71].
However, removal of a CVC was proven to be
unnecessary in 75–90% of cases, even when CR-BSI
was suspected. This may explain, in part, why
catheter exchange over a guidewire, which allows
the avoidance of new venous punctures, has
become common practice in most ICUs. This will
be discussed in more detail in the section on
prevention.
Several studies have reported successful treat-
ment of CRIs, particularly bacteremia due to coa-
gulase-negative staphylococci, with intravenous
antibiotics (vancomycin with or without amino-
glycoside) and without removal of the catheter.
The technique of antibiotic lock may be particu-
larly helpful in avoiding difficult vascular access
replacement in patients with implanted or perma-
nent devices [72]. However, catheter retention may
result in a several-fold higher risk for the recur-
rence of bloodstream infections with resistant
micro-organisms or yeasts [73].
Although some authors recommend no treat-
ment once the catheter is removed, many autho-
rities prefer to treat with an appropriate antibiotic
course (5–7 days for uncomplicated coagulase-
negative staphylococci). In patients with S. aureus
CRIs, treatment duration should be 10–14 days.
Furthermore, recent data suggested that a transe-
sophageal echocardiogram may help to identify
vegetation(s) which require specific management
in a significant proportion of patients [74]. In any
case, antimicrobial agents should then be adapted
according to susceptibility testing. Knowledge of
the ecology of CRIs in particular institutions is
especially useful for empiric antibiotic treatment
[11,56].
Relapse, continuous fever, or bacteremia,
despite removal of the catheter is consistent with
the suspicion of a persistent focus of infection. This
implies prolonged or modified antimicrobial treat-
ment and an active search for a CRI complicating
another venous line, metastatic abscess, septic
thrombophlebitis, or endocarditis. Following com-
pletion of treatment, careful follow-up is required
due to the frequent occurrence of late complica-
tions [11,56].
P R E V E N T I O N
More than 50% of patients admitted to ICUs are
already colonized at the time of admission with the
organism responsible for subsequent infection
[75]. Nevertheless, the prevention of CRIs relies
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on careful control of all the factors associated with
the colonization of vascular accesses by micro-
organisms; evidence-based guidelines and pre-
ventive measures have been published by the
Hospital Infections Control Practices Advisory
Committee [59]. Recently, this topic was also
extensively reviewed elsewhere [76,77]. However,
most of these measures are supported by clinical
studies with a limited strength of evidence. Some
are discussed below.
Hand hygiene measures
Infection prevention is mostly based on the appli-
cation of standard precautions [78]. A strict adher-
ence to hand hygiene measures (hand washing
and/or hand disinfection) and to aseptic techni-
ques in caring for patients and devices is the key
requirement of these precautions [79].
There have been persistent reports of low-level
compliance with hand hygiene, particularly in
ICUs [80,81]. Experience with alcohol-based han-
drubs showed that hand disinfection may reduce
hand contamination more than handwashing. This
may also save precious time in the ICU where
theoretically almost two-thirds of the staff’s work-
ing time could be required for optimal adherence
to infection control guidelines [82–84].
However, following successful interventions,
compliance with hand hygiene decreased again
over the next few months [84]. We recently showed
that the promotion of an elementary bedside hand
disinfection technique, by a hospital-wide educa-
tion campaign, resulted in a sustained improve-
ment in compliance with hand hygiene guidelines
from 48% to 66% over a 4-year period [85]. In addi-
tion, during the same period, the prevalence of
overall NIs decreased significantly from 17% to 9%.
Technique of catheter insertion
Skin preparation should include hair-cutting
rather than shaving [40,42]. Maximal sterile barrier
precautions during insertion, including not only
small fenestrated drapes and the use of sterile
gloves, but also gown, cap, mask and a large
drape, can minimize catheter colonization and
further CRIs [86]. Rigorous cleansing and disin-
fection of the insertion site is regarded as a key
point. Povidone iodine (10%) and alcohol (70%)
are effective, but aqueous chlorhexidine (2%) has
been shown to be superior in preventing CVC
colonization [87]. An alcohol-based preparation
of chlorhexidine gluconate (0.5%) may combine
the advantages of a greater antimicrobial spec-
trum, very rapid killing of skin micro-organisms,
and fast drying time at low cost.
Topical antimicrobial ointments have been pro-
posed to prevent catheter colonization, but they
favour colonization by resistant organisms and are
no longer recommended [59].
Site of insertion
Central lines inserted in the jugular site are more
likely to be colonized than those inserted by the
subclavian route [27,31,54]. This is due to factors
favoring skin colonization, such as proximity of
oropharyngeal secretions, higher skin tempera-
ture, difficulties in immobilizing the catheter
and maintaining an optimal dressing, particularly
in men [27]. CVCs inserted through the femoral
route have not been reported to be more frequently
responsible for infectious complications, but may
be associated with a higher rate of deep venous
thrombosis. Accordingly, insufficient data are pre-
sently available to recommend their use [88].
A meta-analysis suggested that tunnelled short-
term CVCs are associated with a decreasing rate of
CRI, but this may be the case only for those
inserted in the jugular site [89]. However, an
accompanying editorial highlighted the fact that
drawing of blood through the catheters was not
allowed in the study which must be kept in mind
when determining the positive result of this ana-
lysis [90,91]. This was also the case in a recent
study from the same group which reported that
catheter-related sepsis occurred in five out of 168
patients who received a femoral tunneled CVC, as
compared with 15 out of 168 in non-tunnelled CVC
(relative risk 0.25, CI 0.09–0.72) [92].
Careful fixation of the catheter at the skin exit-
site might avoid complications such as leakage of
the fixing device and movements in the intrader-
mal portion. This technique allows the installation
of small dressings that are easier to secure.
Dressing
Semi-permeable transparent dressings are now
widely used. Easy to place, they allow continuous
observation of the skin insertion site and may
reduce the risk of extrinsic contamination.
However, they promote moisture and bacterial
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proliferation and have been repeatedly associated
with higher CRIs rates in comparison with tradi-
tional gauze dressings [93]. Therefore, the use of
transparent dressings cannot be recommended in
critically ill patients. The precise duration that a
dressing can be safely left on a central line is
unknown, but it should be systematically renewed
every 48–72 h, if an earlier change is not clinically
indicated.
Catheter handling
Currently, except for blood products and lipid
emulsions, administration sets can be safely
replaced every 72 h only [59]. Infusion therapy
teams have been reported to decrease CRI rates.
However, this may not be possible in the ICU and a
recent study suggested that appropriately trained
personnel might be as efficacious [94].
A four-fold decrease of CRI rates was reported
with the use of a new antiseptic hub model in a
prospective survey of 151 subclavian CVCs
inserted for a mean duration of 2 weeks. These
results were associated with a significant reduc-
tion of the CR-BSI attributed to the hub (1% vs.
11%) and with the fact that catheters were
removed for clinical suspicion of CRI (19% vs.
42%) [95]. Such preliminary results call for further
randomized trials.
Catheter replacement and/or guidewire
exchange
The duration of catheterization has been linked to
the risk of CRIs, particularly after 7 days [27,31,96],
but systematic routine replacement of central lines
has failed to prove its efficacy in decreasing the
risk [97].
Guidewire exchange may increase the likeli-
hood of infection of the new catheter, but reduces
the rate of complications associated with CVC
placement in a new site which may be technically
difficult, particularly in severely ill patients [97].
Randomized prospective studies failed to detect
any preventive benefit associated with guidewire
exchange compared to insertion at a new site [98].
For many experts, guidewire exchange with sys-
tematic (semi)quantitative culture of the catheter
tip is mandatory in any case of sepsis without
clinical evidence of another source of infection
[42]. This allows removal of the exchanged
catheter and mandates further insertion at a new
site only if the culture of the removed material is
positive.
Intraluminal antibiotic lock or flush
Intraluminal antibiotic lock as well as flush with
antibiotics have been reported to reduce the rate of
CRIs, but only a few studies have been conducted
in ICU patients [99]. Moreover, the use of anti-
microbial agents for this purpose could lead to the
emergence of vancomycin-resistant Gram-positive
organisms, which must be avoided as the glyco-
peptide antibiotics are the only drugs currently
available for the treatment of infections due to
methicillin-resistant staphylococci and penicillin-
resistant enterococci [59].
Antibiotic- and antiseptic-coated catheters
Several randomized clinical studies suggested that
the use of CVCs impregnated with either chlor-
hexidine and silver sulphadiazine or minocycline
and rifampin was associated with significant
reductions of microbiologically documented CRIs,
from 30% to 45% and from 65% to 80%, respec-
tively [25,26,31,100] [Table 2]. In a meta-analysis
and a cost-effectiveness analysis, Veenstra et al.
suggested that the use of chlorhexidine–sulpha-
diazine-impregnated catheters decreased the inci-
dence of CR-BSI by between 1.2% and 3.4%,
corresponding to a cost saving between $68 and
$391 per catheter used [101].
As compared to the chlorhexidine–sulphadia-
zine-coated catheters the minocycline–rifampin-
impregnated catheter was reported to be asso-
ciated with significantly lower colonization (rela-
tive risk 0.35; CI 0.24–0.55) and CR-BSIs (relative
risk 0.08; CI 0.01–0.63) [27]. The authors argue that
this difference may be due, in part, to the absence
of silver–sulphadiazine in the intraluminal sur-
face. This is consistent with another study in which
the silver/chlorhexidine catheters were not asso-
ciated with a reduction of the CRI rates [28]. Recent
data on the determination of colonization and
residual antimicrobial ex vivo activity after
removal of 113 CVCs that were no longer required
strongly favors this hypothesis [102].
However, the duration of catheter placement
may well have played a role. Impregnated cathe-
ters failed to prevent CRIs in neutropenic cancer
patients with a mean catheterization time of
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20 days as compared to 6, 7 and 8.3 days for others
[25–28]. We confirmed in a meta-analysis that the
potential benefit of these devices may be lost after
7–10 days [103].
Educational programs
Sherertz et al. recently reported that an educa-
tional program of physicians in training can
decrease the risk of CRIs. A 1-day course on
infection control practices and on procedures of
vascular access insertion was shown to reduce the
infection rate by 73%, from 3.3 to 2.4 per 1000 CVC-
days [40] [Table 3]. The educational program
included a 1-h introduction to basic infection con-
trol principles (handhygiene, isolation and barrier
use, handling of patients with resistant organisms
and varicella virus). Thereafter, these students and
physicians rotated through a series of 1-h stations,
during which they received 5–15 min of didactic
instruction followed by hands-on instruction that
was overseen by faculty members. Training was
provided in (i) blood-draws through vascular
lines, (ii) arterial puncture, (iii) insertion of arterial
lines and CVCs, (iv) peripheral venous catheter
insertion, (v) phlebotomy, and (vi) urinary cathe-
ter insertion. Participants were also instructed to
change dressings and intravenous tubing every
3 days and not to adhere to fixed schedules for
changing CVCs.
We recently completed a study to evaluate the
impact of a global strategy targeted at the reduc-
tion of CRIs in 3154 critically ill patients consecu-
tively admitted to a medical ICU. Specific
guidelines included in the strategy and implemen-
ted through an educational program targeted at
vascular access care are discussed in the preceding
sections and summarized in Table 6. The program
consisted of slide-show-based educational sessions
and bedside training of the entire staff, including
nurses. Following the introduction of the program,
the incidence density of exit-site catheter infection
decreased by 64%, and that of BSI by 67%.
Although the overall exposure to CVC did not
significantly differ between the control and
the intervention periods (median duration, 4 days,
P ¼ 0.94), the incidence density of bloodstream
infection markedly decreased from 22.9 to 6.2
episodes per 1000 CVC-days due to a reduced
incidence of both microbiologically documented
infection (from 6.6 to 2.3 episodes per 1000 CVC-
days) and clinical sepsis (from 16.3 to 3.9 episodes
per 1000 CVC-days). Overall, the incidence density
of nosocomial infections was reduced by 35%
(from 52.4 to 34.0 episodes per 1000 patient-days).
This corresponded to the prevention of 50–104
nosocomial infections over an 8-month period,
including at least 1–11 cases of primary BSIs,
15–29 cases of clinical sepsis and 15–32 cases of
vascular-access related infections [42].
The impact in terms of reduction of NI in these
two studies was largely superior to that expected
with the use of antimicrobial- and/or antisepsis-
coated catheters [100,101]. Sherertz et al. estimated
that their program was associated with a cost sav-
ing of at least $63 000, perhaps exceeding $800 000.
This may represent the salary of one full-time
infection control nurse per unit involved in the
programme for 1 month to 1 year. This may also
correspond to the anticipated benefit gained with
161–926 catheters for the lower benefit hypothesis,
and from 2035 to 11 767 catheters for the upper
hypothesis [101,104]. Although the precise attri-
butable costs of CRIs remain to be determined,
using a conservative approach, we estimated that
the implementation of our global strategy would
correspond to the annual salary of three to six full-
time infection control nurses [42]. According to the
aforementioned cost-efficacy analysis, this may
also correspond to the anticipated benefit gained
with 540–3103 catheters for the lower benefit
hypothesis, and from 3061 to 6102 catheters for
the upper hypothesis as compared to an average of
400 catheters annually used in the unit [101,104].
These observations indicate that behavioral
changes may have played a key role in the success
of these educational programs, which were based
on multimodal and multidisciplinary approaches,
including communication and education tools,
active participation and positive feedback, and
systematic involvement of institution leaders
[105,106].
C O N C L U S I O N
Catheter-related infections should no longer be
considered as an indirect tribute to sophistica-
ted care or regarded as a fate, but must become
one of the priority targets of a multidisciplinary
approach emphasizing quality-of-care improve-
ment. Although the true impact of the introduction
of antibiotic- and/or antiseptic-coated catheters in
a unit remains to be determined, the data extra-
polated from the studies which explored the
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impact of educational programs suggest that edu-
cational strategies targeted at vascular-access
reduction should be implemented in any unit
before considering the use of coated catheters.
Nevertheless, the use of such sophisticated devices
should probably be considered if the infection
rates remain higher than those reported in the
NNIS despite the introduction of other preventive
measures.
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